- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Lee Greenberger Discusses the Pandemic's Impact on Clinical Trials in Leukemia, Lymphoma
Lee Greenberger, PhD, chief scientific officer of the Leukemia and Lymphoma Society, discusses how the pandemic changed clinical trial enrollment in the leukemia/lymphoma space.
Lee Greenberger, PhD, chief scientific officer of the Leukemia and Lymphoma Society, discusses the COVID-19 pandemic's impact on clinical trial enrollment and the importance of open communication between patients participating in trials and their physicians.
Transcript
From your vantage point, is the pandemic still affecting clinical trial enrollment? What strategies have been effective for keeping trials going?
We definitely saw an impact on trial enrollment during COVID. Many of the clinicians told us about that. There's multiple reasons: Patients were afraid to come in, and the staff to do the work, they were either getting infected [or] they were not coming in. So, it definitely had an impact.
What we have seen is actually that enrollment has come back up, and I think that the NCI [National Cancer Institute] has actually reported on that as well—that, in general, clinical trial enrollment has come back up. Physicians and clinics have learned to deal with it, and I don't think that patients should be as concerned.
That being said, patients need to report if they get an infection to their physician on a clinical trial. As I said, there are steps that can be taken within the first 5 days. Patients should not hesitate to contact their physician if they're on a clinical trial and in the event that they get COVID.
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
